Algeria Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Algeria Pharmaceuticals and Healthcare Report Q3 2013 May 22nd 2013, 00:00 BMI View: Algerian authorities appear committed to healthcare development programme, the 2010-2014 tranche of which envisages the construction of more than 150 new hospitals and numerous other facilities. This expansion of medical services will provide an impetus for pharmaceutical consumption growth, which should also benefit from an expansion of private healthcare that is of increasing appeal to the country’s growing middle class. However, we caution that cost-containment pressures are likely to prioritise generic and locally and regionally imported medicines over novel drugs. Headline Expenditure Projections: ?? Pharmaceuticals: DZD246.75bn (US$3.17bn) in 2012 to DZD272.62bn (US$3.63bn) in 2013; +10.5% in local currency … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=97283. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/algeria-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions